Home > Products > Tumor Cell Lines > Human Tumor Cell Lines >
KHYG-1 | ||||
|---|---|---|---|---|
| Product Name | KHYG-1 | |||
| Price | Get Quote | |||
| Product Code | KHYG1; KHYG | |||
| Cat.No | ABC-TC0506 | Species | Human | |
| Size/Quantity | 1 vial | Biosafety Level | 1 | |
| Shipping Info | Dry Ice | Storage | Liquid Nitrogen | |
| Description | KHYG-1, a natural killer (NK) leukemia cell line, was established from the blood of a patient with NK cell malignancies. KHYG-1 shows the morphology of large granular lymphocytes with a large nucleus, coarse chromatin, conspicuous nucleoli, and abundant basophilic cytoplasm with many azurophilic granules.
Why choose KHYG-1 from AcceGen? AcceGen supports KHYG-1 cells with excellent quality and the best cell viability. KHYG-1 is prepared by professional operators, and every lot of KHYG-1 is tested with a comprehensive quality assurance system to satisfy customer with our good service, based on the tests of sterility, viability of post-thaw, identification using STR analysis, and growth state. | |||
| Source Organ | Peripheral Blood | |||
| Recommended Medium And Supplement | RPMI 1640 + 10% FBS | |||
| Citation Guide | When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID). | |||
| Application | FOR RESEARCH USE ONLY KHYG-1 provides a valuable model for studying the biology of normal and malignant NK cells, and leukemogenesis. NK cells were thought to be potential candidate cells for adoptive immunotherapy of malignancies, however, the endogenous NK and lymphokine-activated killer cells did not support sufficient cytotoxicity. Through the investigation of enhanced cytotoxicity of permanent NK cell lines, such as KHYG-1, the limitation of autologous NK cells may be overcome, and NK cells may generate greater killing ability for clinical application. | |||
| Growth Conditions | 37 ℃, 5% CO2 | |||
| Cell Type | Lymphocyte-like | |||
| Growth Mode | Suspension | |||
| Product Type | Human Leukemia Cell Lines | |||
| Product Image |  | |||
The immunophenotype of KHYG-1 cells contains CD1−, CD2+, surface CD3−, cytoplasmic CD3ε+, CD7+, CD8αα+, CD16−, CD25−, CD33+, CD34−, CD56+, CD57−, CD122+, CD132+, and TdT−. KHYG-1 has a point mutation in exon 7 of the p53 gene, which is identical to the mutation found in primary leukemia cells. KHYG-1 is a highly cytotoxic cell line against the leukemia cell lines EM2, EM3, and HL60, and this cytolytic capacity of KHYG-1 might be involved with activation receptor NKp44 and its adaptor, DAP12, NKG2D, and constitutively phosphorylated ERK2.- ONLINE INQUIRY
- PRODUCT REVIEWS
Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
